Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/33890
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-09-19T08:17:18Z | - |
dc.date.available | 2023-09-19T08:17:18Z | - |
dc.date.issued | 2014-07-17 | - |
dc.identifier.citation | Ünal, O. K. vd. (2014). "Investigation of genotoxicity in acromegaly from peripheral blood lymphocyte cultures using a micronucleus assay". Journal of Clinical Endocrinology and Metabolism, 99(10), E2060-E2066. | en_US |
dc.identifier.issn | 0021-972X | - |
dc.identifier.issn | 1945-7197 | - |
dc.identifier.uri | https://doi.org/10.1210/jc.2014-1641 | - |
dc.identifier.uri | https://academic.oup.com/jcem/article/99/10/E2060/2836233?login=true | - |
dc.identifier.uri | http://hdl.handle.net/11452/33890 | - |
dc.description.abstract | Context: Although patients with acromegaly may have an increased risk of developing several types of cancers, the degree of risk for malignancy in these patients is unresolved. Objective: The present study aimed to investigate the potential genotoxic effects of acromegaly on the cell cycle in peripheral blood lymphocyte cultures. Design: This was a single center, crossover, case-control study conducted on the acromegalic patients in Turkey. Setting: The study was conducted in the outpatient clinic of a university hospital. Patients: Seventy-one consecutively screened acromegalic patients and 56 controls participated in the study. Intervention: Patients were included, regardless of the disease activity status and their treatment duration before the study. Main Outcome Measures: The primary end point was the frequency of micronucleus (MN) in the peripheral blood lymphocyte cultures, and the secondary end point was its clinical correlations. Results: The MN level was 3.82 +/- 1.49 in the control group and 18.00 +/- 6.13 in the acromegalic group (P < .01), whereas the nuclear division index (NDI) was 1.79 +/- 0.12 in the control group and 1.68 +/- 0.07 in the acromegalic group (P < .01). Neither MN nor NDI was correlated with age, GH, IGF-I, initial GH, initial IGF-I, duration of the remission period, and initial tumor size. Only the MN level was positively correlated with the duration of disease (r = 0.323, P = .014). Conclusion: Our results indicated that acromegalic patients had genotoxic damage at a substantial level, and there was a positive correlation between the duration of disease and genotoxicity level. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Endocrine Society | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Growth-hormone receptor | en_US |
dc.subject | Exposure | en_US |
dc.subject | Dna-damage present | en_US |
dc.subject | Risk | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Frequency | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Cell-culture | en_US |
dc.subject | Cancer-patients | en_US |
dc.subject | Breast-cancer | en_US |
dc.subject | Endocrinology & metabolism | en_US |
dc.subject.mesh | Acromegaly | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Cells, cultured | en_US |
dc.subject.mesh | Cross-over studies | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Human growth hormone | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Insulin-like growth factor I | en_US |
dc.subject.mesh | Lymphocytes | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Micronucleus tests | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Mutagenicity tests | en_US |
dc.subject.mesh | Neoplasms | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.mesh | Turkey | en_US |
dc.title | Investigation of genotoxicity in acromegaly from peripheral blood lymphocyte cultures using a micronucleus assay | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000343423300031 | tr_TR |
dc.identifier.scopus | 2-s2.0-84907612373 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolizma Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Bölümü. | tr_TR |
dc.contributor.orcid | 0000-0002-3595-6286 | tr_TR |
dc.contributor.orcid | 0000-0002-7687-3284 | tr_TR |
dc.identifier.startpage | E2060 | tr_TR |
dc.identifier.endpage | E2066 | tr_TR |
dc.identifier.volume | 99 | tr_TR |
dc.identifier.issue | 10 | tr_TR |
dc.relation.journal | Journal of Clinical Endocrinology and Metabolism | en_US |
dc.contributor.buuauthor | Ünal, Oǧuz Kaan | - |
dc.contributor.buuauthor | Cinkılıç, Nilüfer | - |
dc.contributor.buuauthor | Gül, Özen Öz | - |
dc.contributor.buuauthor | Cander, Soner | - |
dc.contributor.buuauthor | Vatan, Özgür | - |
dc.contributor.buuauthor | Ersoy, Canan Özyardımcı | - |
dc.contributor.buuauthor | Yılmaz, Dilek | - |
dc.contributor.buuauthor | Tuncel, Ercan | - |
dc.contributor.researcherid | AAI-1005-2021 | tr_TR |
dc.contributor.researcherid | AAH-5296-2021 | tr_TR |
dc.contributor.researcherid | O-7508-2015 | tr_TR |
dc.contributor.researcherid | AAH-8861-2021 | tr_TR |
dc.identifier.pubmed | 24963647 | tr_TR |
dc.subject.wos | Endocrinology & metabolism | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q1 | en_US |
dc.contributor.scopusid | 55042241400 | tr_TR |
dc.contributor.scopusid | 26533892300 | tr_TR |
dc.contributor.scopusid | 26040787100 | tr_TR |
dc.contributor.scopusid | 25027068600 | tr_TR |
dc.contributor.scopusid | 16235098100 | tr_TR |
dc.contributor.scopusid | 6701485882 | tr_TR |
dc.contributor.scopusid | 6701369462 | tr_TR |
dc.contributor.scopusid | 7006929833 | tr_TR |
dc.subject.scopus | Micronucleus Tests; DNA Damage; Cytokinesis | en_US |
dc.subject.emtree | Acromegaly | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Age | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Cell cycle | en_US |
dc.subject.emtree | Cellular parameters | en_US |
dc.subject.emtree | Clinical assessment | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Disease activity | en_US |
dc.subject.emtree | Disease duration | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Genotoxicity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Human cell | en_US |
dc.subject.emtree | Human cell culture | en_US |
dc.subject.emtree | Lymphocyte culture | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Methodology | en_US |
dc.subject.emtree | Micronucleus | en_US |
dc.subject.emtree | Micronucleus test | en_US |
dc.subject.emtree | Outpatient department | en_US |
dc.subject.emtree | Peripheral lymphocyte | en_US |
dc.subject.emtree | Population based case control study | en_US |
dc.subject.emtree | Remission | en_US |
dc.subject.emtree | Treatment duration | en_US |
dc.subject.emtree | Tumor volume | en_US |
dc.subject.emtree | Turkey (republic) | en_US |
dc.subject.emtree | University hospital | en_US |
dc.subject.emtree | Acromegaly | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Cell culture | en_US |
dc.subject.emtree | Crossover procedure | en_US |
dc.subject.emtree | Cytology | en_US |
dc.subject.emtree | Epidemiology | en_US |
dc.subject.emtree | Genetics | en_US |
dc.subject.emtree | Lymphocyte | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Mutagen testing | en_US |
dc.subject.emtree | Neoplasms | en_US |
dc.subject.emtree | Physiology | en_US |
dc.subject.emtree | Procedures | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Turkey | en_US |
dc.subject.emtree | Growth hormone | en_US |
dc.subject.emtree | Somatomedin c | en_US |
dc.subject.emtree | Human growth hormone | en_US |
dc.subject.emtree | Somatomedin c | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.